Suppr超能文献

[血管扩张剂对慢性心力衰竭患者心律失常特征及发生率的影响]

[Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure].

作者信息

Bechler-Lisińska J, Cholewa M, Górski L, Markiewicz K

机构信息

Institut für Innere Medizin, Medizinischen Akademie Lódź.

出版信息

Z Gesamte Inn Med. 1990 Mar 1;45(3):71-6.

PMID:2186579
Abstract

In 50 patients with chronic congestive heart failure (CCHF, III or IV class), aged 62.8 +/- 9.1 years, who were treated with digoxin (Dx) and furosemide (F) (investigation A), continuous 24-hour ecg registration was performed according to Holter. Next, this treatment was extended by two-week administration of nifedipine (N) or isosorbide dinitrate (S) (investigation B), followed by one-month addition of captopril (Cp) (investigation C). During the last two weeks Dx, F, N or Dx, F, S were administered with Cp being withdrawn (investigation D). At the end of each stage of the treatment ecg registration was repeated according to Holter. At the same time, during the investigation A there were performed determinations of blood serum sodium, potassium and digoxin concentrations, two-dimensional echocardiography and evaluation of submaximal exercise tolerance. In 96 per cent of patients with CCHF, treated with Dx and F, cardiac rhythm disturbances were found. In 53.3 per cent life-threatening ventricular arrhythmias occurred, including unstable ventricular tachycardia in 11.1 per cent of patients. Addition of N or S to the classical treatment did not decrease either patient number or amounts of cardiac rhythm disturbances in individual classes according to Lown. Also Cp did not affect numbers of patients with cardiac rhythm disturbances, but it decreased numbers of patients with life-threatening ventricular arrhythmias from 53.3 per cent to 28.9 per cent (from 24/45 to 13/45). At the same time, Cp significantly decreased numbers of ventricular arrhythmias in class 3 and 4a (p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对50例年龄为62.8±9.1岁的慢性充血性心力衰竭(CCHF,Ⅲ或Ⅳ级)患者采用地高辛(Dx)和呋塞米(F)进行治疗(研究A),并根据动态心电图监测仪进行连续24小时心电图记录。接下来,在经典治疗基础上延长两周给予硝苯地平(N)或硝酸异山梨酯(S)(研究B),随后加用卡托普利(Cp)一个月(研究C)。在最后两周停用Cp,给予Dx、F、N或Dx、F、S(研究D)。在治疗的每个阶段结束时,再次根据动态心电图监测仪进行心电图记录。同时,在研究A期间测定血清钠、钾和地高辛浓度,进行二维超声心动图检查并评估次极量运动耐量。在接受Dx和F治疗的CCHF患者中,96%出现心律失常。53.3%发生危及生命的室性心律失常,其中11.1%的患者出现不稳定室性心动过速。在经典治疗基础上加用N或S并未减少心律失常患者数量或各类心律失常的发生量(根据洛恩分级)。Cp也未影响心律失常患者数量,但将危及生命的室性心律失常患者数量从53.3%降至28.9%(从24/45降至13/45)。同时,Cp显著减少了3级和4a级室性心律失常的数量(p<0.05)。(摘要截断于250字)

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验